|
| 37976264 | Clinical Predictors of Early and Late Endoscopic Recurrence Following Ileocolonic Resection in Crohn's Disease. | J Crohns Colitis | 2024 |
| 38015321 | Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD). | Dig Dis Sci | 2024 |
| 38082490 | The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials. | J Am Soc Nephrol | 2024 |
| 37976264 | Clinical Predictors of Early and Late Endoscopic Recurrence Following Ileocolonic Resection in Crohn's Disease. | J Crohns Colitis | 2024 |
| 37556401 | Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study. | Inflamm Bowel Dis | 2024 |
| 38082490 | The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials. | J Am Soc Nephrol | 2024 |
| 38015321 | Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD). | Dig Dis Sci | 2024 |
| 37556401 | Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study. | Inflamm Bowel Dis | 2024 |
| 34971808 | Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis. | Clin Gastroenterol Hepatol | 2023 |
| 36308435 | Trans-ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort. | Hum Mol Genet | 2023 |
| 35644340 | Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. | Clin Gastroenterol Hepatol | 2023 |
| 35816130 | The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients. | Inflamm Bowel Dis | 2023 |
| 36343846 | Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. | Clin Gastroenterol Hepatol | 2023 |
| 36280102 | Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab. | Clin Gastroenterol Hepatol | 2023 |
| 35998072 | Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD. | Inflamm Bowel Dis | 2023 |
| 35731568 | Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the Literature. | Inflamm Bowel Dis | 2023 |
| 37762524 | A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination. | Int J Mol Sci | 2023 |
| 37756315 | Genetic variation in environmental enteropathy and stunting in Zambian children: A pilot genome wide association study using the H3Africa chip. | PLoS One | 2023 |
| 37841595 | Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information. | iScience | 2023 |
| 37789059 | Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards. | Nat Rev Gastroenterol Hepatol | 2023 |
| 37773982 | Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2023 |
| 37547534 | Outcomes in ANCA-Associated Vasculitis in Scotland: Validation of the Renal Risk Score in a Complete National Cohort. | Kidney Int Rep | 2023 |
| 37080976 | Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients. | Nat Commun | 2023 |
| 37080587 | Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. | Gut | 2023 |
| 36496198 | Avacopan for ANCA-associated vasculitis - information for prescribers. | Nephrol Dial Transplant | 2023 |
| 37262302 | Sex-Dimorphic Analyses Identify Novel and Sex-Specific Genetic Associations in Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2023 |
| 36625223 | Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors. | J Intern Med | 2023 |
| 37061107 | HLA-DQA1⿿05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2023 |
| 36744850 | Potential determinants of low circulating glucagon-like peptide 2 concentrations in Zambian children with non-responsive stunting. | Exp Physiol | 2023 |
| 36662167 | Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. | Inflamm Bowel Dis | 2023 |
| 34971808 | Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis. | Clin Gastroenterol Hepatol | 2023 |
| 37756315 | Genetic variation in environmental enteropathy and stunting in Zambian children: A pilot genome wide association study using the H3Africa chip. | PLoS One | 2023 |
| 37789059 | Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards. | Nat Rev Gastroenterol Hepatol | 2023 |
| 37547534 | Outcomes in ANCA-Associated Vasculitis in Scotland: Validation of the Renal Risk Score in a Complete National Cohort. | Kidney Int Rep | 2023 |
| 37841595 | Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information. | iScience | 2023 |
| 37773982 | Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2023 |
| 37762524 | A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination. | Int J Mol Sci | 2023 |
| 35644340 | Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. | Clin Gastroenterol Hepatol | 2023 |
| 35731568 | Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the Literature. | Inflamm Bowel Dis | 2023 |
| 35816130 | The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients. | Inflamm Bowel Dis | 2023 |
| 37061107 | HLA-DQA1⿿05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2023 |
| 37080976 | Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients. | Nat Commun | 2023 |
| 37080587 | Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. | Gut | 2023 |
| 37262302 | Sex-Dimorphic Analyses Identify Novel and Sex-Specific Genetic Associations in Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2023 |
| 36625223 | Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors. | J Intern Med | 2023 |
| 36744850 | Potential determinants of low circulating glucagon-like peptide 2 concentrations in Zambian children with non-responsive stunting. | Exp Physiol | 2023 |
| 36496198 | Avacopan for ANCA-associated vasculitis - information for prescribers. | Nephrol Dial Transplant | 2023 |
| 36662167 | Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. | Inflamm Bowel Dis | 2023 |
| 36280102 | Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab. | Clin Gastroenterol Hepatol | 2023 |
| 35998072 | Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD. | Inflamm Bowel Dis | 2023 |